Literature DB >> 6832202

The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia.

K Lamb, C M Bradshaw, E Szabadi.   

Abstract

The responsiveness of human eccrine sweat glands to intradermally injected choline and carbachol was studied in vivo using a plastic paint impression method. Both drugs exerted consistent dose-related effects, choline being significantly less potent than carbachol. The responses to both drugs attained a maximum level approximately 3 min after the injection, but the responses to choline had a less pronounced peak and declined more slowly than the response to carbachol. The response to choline, but not the response to carbachol, was antagonised by hemicholinium-3. Young males showed greater responsiveness to both drugs than young females, this being reflected in higher maxima of the dose-response curves obtained for the males. Smaller responses to both drugs were observed in old females than in young females, this being reflected in lower maxima of the dose-response curves obtained for the elderly group. A group of elderly female patients with clinical diagnoses of Alzheimer-type dementia showed smaller responses to both drugs than the group of non-demented elderly females. The results show that choline can stimulate eccrine sweat glands, possibly by an indirect mechanism involving active uptake and metabolic conversion to acetylcholine. The reduced responsiveness seen in the patients suffering from Alzheimer-type dementia could reflect either a loss of function of cholinergic sympathetic neurones or impaired functioning of the sweat glands themselves.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832202     DOI: 10.1007/bf00613927

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  AGE AND SEX DIFFERENCES IN SPONTANEOUS, ADRENERGIC AND CHOLINERGIC HUMAN SWEATING.

Authors:  A SIVER; W MONTAGNA; I KARACAN
Journal:  J Invest Dermatol       Date:  1964-10       Impact factor: 8.551

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Comparison of the effects of adrenoceptor and cholinoceptor agonists on sweat gland activity in man.

Authors:  E Szabadi; P Gaszner; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 6.  Choline analogs as potential tools in developing selective animal models of central cholinergic hypofunction.

Authors:  A Fisher; I Hanin
Journal:  Life Sci       Date:  1980-11-03       Impact factor: 5.037

7.  A technique for studying the effects of drugs on human sweat gland activity.

Authors:  M Clubley; C E Bye; T Henson; A W Peck; C Riddington
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

8.  Pilocarpine iontophoresis sweat testing results of seven years' experience.

Authors:  H Shwachman; A Mahmoodian
Journal:  Bibl Paediatr       Date:  1967

9.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

10.  Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

Authors:  P Davies; A H Verth
Journal:  Brain Res       Date:  1977-12-16       Impact factor: 3.252

View more
  8 in total

1.  In vivo studies on receptor pharmacology of the human eccrine sweat gland.

Authors:  P A Low; T L Opfer-Gehrking; M Kihara
Journal:  Clin Auton Res       Date:  1992-02       Impact factor: 4.435

2.  Altered pupillary size and darkness and light reflexes in Alzheimer's disease.

Authors:  R Prettyman; P Bitsios; E Szabadi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

3.  Effects of locally and systemically administered cholinoceptor antagonists on the secretory response of human eccrine sweat glands to carbachol.

Authors:  J Longmore; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

4.  The effects of a psychological "stressor" and raised ambient temperature on the pharmacological responsiveness of human eccrine sweat glands: implications for sweat gland hyper-responsiveness in anxiety states.

Authors:  M D van den Broek; C M Bradshaw; E Szabadi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  The effect of diazepam on the responsiveness of human eccrine sweat glands to carbachol: influence of ambient temperature.

Authors:  W Banjar; J Longmore; C M Bradshaw; E Szabadi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Effects of locally administered anticholinesterase agents on the secretory response of human eccrine sweat glands to acetylcholine and carbachol.

Authors:  J Longmore; B Jani; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

7.  Hyper-responsiveness of eccrine sweat glands to carbachol in anxiety neurosis: comparison of male and female patients.

Authors:  J M Buceta; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

8.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.